Inventor · disambiguated record
Thomas Schurpf
Also filed as: SCHURPF THOMAS
18 granted patents·18 pending applications·169 citations·filing 2015–2025
94Inventor score
Files withSCHOLAR ROCK INC36
Top patents by PatentIndex Score
36 records- 0197US9580500B2Compositions and methods for growth factor modulationSCHOLAR ROCK INC·Filed 2015·Granted Feb 28, 2017·36 cites·8 claims
- 0297US9573995B2Compositions and methods for growth factor modulationSCHOLAR ROCK INC·Filed 2015·Granted Feb 21, 2017·41 cites·10 claims
- 0397US9399676B2Compositions and methods for growth factor modulationSCHOLAR ROCK INC·Filed 2015·Granted Jul 26, 2016·38 cites·7 claims
- 0495US10597443B2Compositions and methods for growth factor modulationSCHOLAR ROCK INC·Filed 2017·Granted Mar 24, 2020·16 cites·23 claims
- 0594US11827698B2Compositions and methods for growth factor modulationSCHOLAR ROCK INC·Filed 2021·Granted Nov 28, 2023·2 cites·23 claims
- 0694US10981981B2Compositions and methods for growth factor modulationSCHOLAR ROCK INC·Filed 2018·Granted Apr 20, 2021·5 cites·24 claims
- 0794US9758576B2Compositions and methods for growth factor modulationSCHOLAR ROCK INC·Filed 2015·Granted Sep 12, 2017·13 cites·10 claims
- 0894US9758577B2Compositions and methods for growth factor modulationSCHOLAR ROCK INC·Filed 2016·Granted Sep 12, 2017·13 cites·16 claims
- 0990US12454570B2Compositions and methods for growth factor modulationSCHOLAR ROCK INC·Filed 2023·Granted Oct 28, 2025·0 cites·19 claims
- 1088US11214614B2LTBP complex-specific inhibitors of TGFβ and uses thereofSCHOLAR ROCK INC·Filed 2020·Granted Jan 4, 2022·2 cites·3 claims
- 1186US11365245B2LTBP complex-specific inhibitors of TGFβ and uses thereofSCHOLAR ROCK INC·Filed 2021·Granted Jun 21, 2022·1 cites·8 claims
- 1285US12122823B2Isoform-selective TGFB1 inhibitors and use thereofSCHOLAR ROCK INC·Filed 2021·Granted Oct 22, 2024·1 cites·13 claims
- 1382US2025179164A1LTBP COMPLEX-SPECIFIC INHIBITORS OF TGFb AND USES THEREOFSCHOLAR ROCK INC·Filed 2024·Application pending·0 cites
- 1478US2024016928A1Isoform-specific, context-permissive tgfb1 inhibitors and use thereofSCHOLAR ROCK INC·Filed 2023·Application pending·0 cites
- 1577US11130803B2Isoform-selective TGFβ1 inhibitors and use thereofSCHOLAR ROCK INC·Filed 2019·Granted Sep 28, 2021·1 cites·10 claims
- 1677US2025215072A1Isoform-selective tgfb1 inhibitors and use thereofSCHOLAR ROCK INC·Filed 2024·Application pending·0 cites
- 1775US12173059B2LTBP complex-specific inhibitors of TGFβ and uses thereofSCHOLAR ROCK INC·Filed 2022·Granted Dec 24, 2024·0 cites·20 claims
- 1869US2023348583A1TGFbeta1-BINDING IMMUNOGLOBULINS AND USE THEREOFSCHOLAR ROCK INC·Filed 2023·Application pending·0 cites
- 1967US12281159B2TGFβ antibodies, methods and usesSCHOLAR ROCK INC·Filed 2021·Granted Apr 22, 2025·0 cites·26 claims
- 2067US2018022798A1Compositions and methods for growth factor modulationSCHOLAR ROCK INC·Filed 2017·Application pending·0 cites
- 2166US2018016332A1Compositions and methods for growth factor modulationSCHOLAR ROCK INC·Filed 2017·Application pending·0 cites
- 2264US2017210798A1Compositions and methods for growth factor modulationSCHOLAR ROCK INC·Filed 2017·Application pending·0 cites
- 2364US2019209682A1Isoform-specific, context-permissive tgfb1 inhibitors and use thereofSCHOLAR ROCK INC·Filed 2019·Application pending·0 cites
- 2463US12252531B2Methods of screening for high-affinity, isoform-selective TGFβ1 inhibitorsSCHOLAR ROCK INC·Filed 2019·Granted Mar 18, 2025·0 cites·5 claims
- 2560US2018207267A1Isoform-specific, context-permissive tgfb1 inhibitors and use thereofSCHOLAR ROCK INC·Filed 2018·Application pending·0 cites
- 2658US2024301073A1LTBP COMPLEX-SPECIFIC INHIBITORS OF TGFb1 AND USES THEREOFSCHOLAR ROCK INC·Filed 2022·Application pending·0 cites
- 2758US2025257125A1HIGH-AFFINITY, ISOFORM-SELECTIVE TGFß1 INHIBITORS AND USE THEREOFSCHOLAR ROCK INC·Filed 2025·Application pending·0 cites
- 2856US2024294623A1Tgf-beta inhibitors and therapeutic use thereofSCHOLAR ROCK INC·Filed 2022·Application pending·0 cites
- 2951US2023057012A1Tgfb inhibitors and use thereofSCHOLAR ROCK INC·Filed 2021·Application pending·0 cites
- 3050US2023050148A1Tgf-beta inhibitors and use thereofSCHOLAR ROCK INC·Filed 2021·Application pending·0 cites
- 3147US2019292254A1TGFBeta Antibodies, Methods and UsesSCHOLAR ROCK INC·Filed 2017·Application pending·0 cites
- 3246US11643459B2TGFβ1-binding immunoglobulins and use thereofSCHOLAR ROCK INC·Filed 2017·Granted May 9, 2023·0 cites·15 claims
- 3345US2021340238A1TGFß1 INHIBITORS AND USE THEREOFSCHOLAR ROCK INC·Filed 2019·Application pending·0 cites
- 3444US12358992B2LTBP complex-specific inhibitors of TGF-beta 1 and uses thereofSCHOLAR ROCK INC·Filed 2018·Granted Jul 15, 2025·0 cites·4 claims
- 3544US2020181251A1Lrrc33 inhibitors and use thereofSCHOLAR ROCK INC·Filed 2018·Application pending·0 cites
- 3640US2017073406A1Compositions and methods for growth factor modulationSCHOLAR ROCK INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thomas Schurpf files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →